DePuy Synthes Q3 US sales up 3%, worldwide sales drop 18.9%: 6 key notes

Johnson & Johnson’s orthopedics subsidiary DePuy Synthes reported a drop in international and overall sales in the third quarter of 2015.

Advertisement

Here are five key notes from the report:

 

1. The U.S. sales were up 3.1 percent over the third quarter last year, reaching $1.3 billion.

 

2. The international orthopedics sales dropped 18.9 percent from $1 billion last year during the third quarter to $869 million for 2015.

 

3. Worldwide orthopedics sales hit $2.1 billion for the third quarter, down 7 percent from the same period last year.

 

4. At the nine months end, the U.S. sales were up 2.2 percent overall, reaching $3.9 billion.

 

5. International orthopedics sales dropped 14.2 percent in for the first nine months of 2015 over the first nine months of 2014.

 

6. Worldwide, the orthopedics business sales dropped 5.5 percent over the same period last year, going from $7.2 billion at the nine months end in 2024 to $6.8 billion in the same period this year.

 

More articles on orthopedic devices:
SeaSpine creates general counsel position: 5 things to know
IlluninOss Medical partners with Orthovactive
Amendia, Promimic enter into strategic venture: 4 things to know

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.